v3.26.1
Cash, Cash Equivalents and Marketable Securities (Tables)
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
Schedule of Marketable Securities
The amortized cost, unrealized gain (loss) and estimated fair value of the Company’s cash, cash equivalents and marketable securities are as follows:
June 30, 2026
Amortized CostGross Unrealized LossFair Value
(In thousands)
Cash and cash equivalents:
Cash and restricted cash$12,865 $— $12,865 
Money market205,547 — 205,547 
Marketable securities:
U.S. treasuries59,672 (8)59,664 
Corporate bonds8,052 (2)8,050 
$286,136 $(10)$286,126 

December 31, 2025
Amortized Cost
Gross Unrealized Gain
Fair Value
(In thousands)
Cash and cash equivalents:
Cash and restricted cash$7,687 $— $7,687 
Money market168,028 — 168,028 
Marketable securities:
U.S. treasuries9,884 14 9,898 
Corporate bonds152,372 43 152,415 
$337,971 $57 $338,028